Recent rise, page-4

First 4 Last

Share
Profile

Follow
STUMPY62

102 Posts.

11

13/06/25

11:41

Post #: 79420644
Share

Originally posted by insidejob: ↑

Only information I’ve heard this week that has some connection…

“Sanofi is set to acquire Vigil Neuroscience, which as the name implies is a biotech company focused on neurodegenerative diseases in a $470 million deal.Under the terms of the agreement, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash. In addition, Vigil shareholders will receive a non-transferrable CVR for each Vigil share, which will entitle its holders to receive a deferred cash payment of $2 per share, conditioned upon the first commercial sale of its drug, VG3927.VG3927 is a phase 1 small molecule drug meant to treat Alzheimer's. Similar drugs have been developed and approved by the FDA and are made by Eli Lilly and Likwembe, which is a joint venture between Biogen and the Japanese pharmaceutical company, Isai”
From The Special Situations Report: A Biotech Boom: Rumored Deals, Bidding Wars, CVRs, Insider Transactions, and More! – The Special Situations Report Episode #22, 9 Jun 2025https://podcasts.apple.com/ca/podcast/the-special-situations-report/id1790149530?i=1000712073290&r=659This material may be protected by copyright.

Expand

thanks - could be a catalyst

CGS Price at posting: $1.49 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PSC

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Week 31 Wrap: Oz core CPI @ 2.7%! But here come tariffs. Again. Next Friday

Why a Fed rate cut could obliterate your super – and no one's warning you

I88

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

LKO

'Rising demand': Lakes Blue Energy starts well-timed Wombat-5 gas drilling

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.72		Change -0.010(0.58%)		Mkt cap ! $291.1M

Open	High	Low	Value	Volume
$1.73	$1.73	$1.71	$21.33K	12.37K

Buyers (Bids)

No.	Vol.	Price($)
2	1665	$1.71

Sellers (Offers)

Price($)	Vol.	No.
$1.73	83	1

View Market Depth

No.	Vol.	Price($)
2	1665	1.710
1	118	1.695
1	118	1.680
2	8562	1.675
2	19985	1.650

Price($)	Vol.	No.
1.730	83	1
1.740	125	2
1.750	1311	1
1.755	118	1
1.800	5358	1

Last trade - 15.13pm 01/08/2025 (20 minute delay)

CGS (ASX) Chart

Recent rise, page-4

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Week 31 Wrap: Oz core CPI @ 2.7%! But here come tariffs. Again. Next Friday

Why a Fed rate cut could obliterate your super – and no one's warning you

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

'Rising demand': Lakes Blue Energy starts well-timed Wombat-5 gas drilling

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Recent rise, page-4

Top Stories

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Week 31 Wrap: Oz core CPI @ 2.7%! But here come tariffs. Again. Next Friday

Why a Fed rate cut could obliterate your super – and no one's warning you

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

'Rising demand': Lakes Blue Energy starts well-timed Wombat-5 gas drilling

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News